NovoCure (NVCR) Exchange Rate Effect (2016 - 2026)
NovoCure's (NVCR) quarterly Exchange Rate Effect came in at -$130000.0 in Q1 2026, down 157.27% year-on-year from $227000.0 in Q1 2025, and down 71.05% quarter-over-quarter from -$76000.0 in Q4 2025.
NovoCure (NVCR) Exchange Rate Effect (2016 - 2026) Analysis & Trends
NovoCure has disclosed Exchange Rate Effect across 11 years of filings, most recently posting -$130000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$130000.0, down 157.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $37000.0 (down 66.06% YoY), and the FY2025 annual result was $394000.0, up 326.44% from the prior year.
- Exchange Rate Effect came in at -$130000.0 for Q1 2026 at NovoCure, down from -$76000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $265000.0 in Q2 2025 to a low of -$130000.0 in Q1 2026.
- The 5-year median for Exchange Rate Effect is -$25000.0 (2022), against an average of $7294.1.
- Across the five-year window, Exchange Rate Effect sank 3900.0% in 2022 and jumped 505.36% in 2025, its largest moves.
- NovoCure's Exchange Rate Effect stood at $155000.0 in 2022, then gained by 29.03% to $200000.0 in 2023, then plunged by 164.0% to -$128000.0 in 2024, then jumped by 40.62% to -$76000.0 in 2025, then slumped by 71.05% to -$130000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$130000.0 (Q1 2026), -$76000.0 (Q4 2025), and -$22000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 24.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.66 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -2.80 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -4.40 Mn |
| 10 | NovoCure | 1.63 Bn | 1.20 Bn | 135.13 Mn | -130,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130,000.00 |
| Mar 31, 2026 | -130,000.00 |
| Dec 31, 2025 | -76,000.00 |
| Dec 31, 2025 | -76,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Sep 30, 2025 | -22,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Jun 30, 2025 | 265,000.00 |
| Mar 31, 2025 | 227,000.00 |
| Mar 31, 2025 | 227,000.00 |
| Dec 31, 2024 | -128,000.00 |
| Dec 31, 2024 | -128,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | -77,000.00 |
| Jun 30, 2024 | -77,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |